Radius Research – Webinar and Deep Dive with CEO Ram Mukunda & CFO Claudia Grimaldi
Sourcehttps://www.youtube.com/watch?v=gtE3SROFPXg
Sourcehttps://www.youtube.com/watch?v=gtE3SROFPXg
Hamsa Biopharma, which will take the drug — Christened TGR63 — to trials through its parent company in the US, IGC Pharma, hopes it can eventually be made available in the market.
The FIRST natural cannabis-based patent-protected compound that relies on low doses of THC, a psychoactive cannabinoid, and another compound as active agents for the treatment of Alzheimer’s disease.
Researchers in India say they have discovered a promising drug target that may slow or even halt the progression of Alzheimer’s.